Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 17

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 17
---
itation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. PRELIMINARY — SUBJECT TO COMPLETION, DATED MAY 12, 2025 PRELIMINARY PROXY STATEMENT FOR SPECIAL MEETING OF
THE STOCKHOLDERS OF NORTHVIEW ACQUISITION CORPORATION
(A DELAWARE CORPORATION) PROSPECTUS FOR 23,763,623 SHARES OF COMMON STOCK OF NORTHVIEW ACQUISITION
CORPORATION, WHICH WILL BE RENAMED “PROFUSA, INC.” The board of directors of NorthView Acquisition Corporation, a Delaware corporation (“NorthView”, “we” or “our”), has unanimously approved (1) the merger of NV Profusa Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of NorthView (“Merger Sub”), with and into Profusa, Inc. (“Profusa”), a California corporation (the “Merger”), with Profusa surviving the Merger as a wholly owned subsidiary of NorthView (the time that the Merger becomes effective being referred to as the “Effective Time”), pursuant to the terms of the Merger Agreement and Plan of Reorganization, dated as of November 7, 2022, by and among NorthView, Merger Sub and Profusa, as amended and attached to this proxy statement/prospectus as Annex A (as amended, the “Merger Agreement”), as more fully described elsewhere in this proxy statement/prospectus and (2) the other transactions contemplated by the Merger Agreement and documents related thereto (collectively, the “Business Combination”). As used in this proxy statement/prospectus, “New Profusa” refers to NorthView after giving effect to the Business Combination. Pursuant to the Merger Agreement, immediately prior to the Effective Time (as defined in this proxy statement/prospectus), each share of issued and outstanding Profusa preferred stock, par value $0.01, shall be converted into a number of shares of Profusa common stock, par value $0.01 (“Profusa Common Stock”). At the effective time of the Merger, (i) each share of issued and outstanding Profusa Common Stock shall be converted into a number of shares of New Profusa common stock, par value $0.0001 (“New Profusa Common Stock”), based on the Exchange Ratio described below, (ii) each option to purchase Profusa Common Stock shall be converted into an option to